Abstract:Interferons (IFN) are natural defense factors in vertebrates. This family of cytokines regulates antiviral, anti‐tumor, immuno‐modulatory activities, and regulation of cell differentiation. The biological activities of type I interferons (IFNs) are mediated by their binding to a heterodimer receptor complex (IFNAR1 and IFNAR2), resulting in the activation of the JAK (JAK1 and TYK2)‐STAT (1, 2, 3, 5 isotypes) signaling pathway. Although several studies have indicated that IFN‐α and IFN‐β can activate complexes containing STAT6, the biological role of this activation is still unknown. It is known that Daudi cells and B cells transformed with Epstein‐Barr virus (EBV) resistant to the anti‐proliferative effect of IFN‐α display a decrease in type I IFN‐mediated activation of STAT6. Therefore, it is suggested that complexes containing STAT6 may play a more general role in gene activation necessary for the anti‐proliferative effects of type I IFN. To determine the IFN‐activated‐STAT6 regulated genes, we performed a Chip‐chip experiment using anti‐STAT6 antibody and subsequently determined the mRNA expression levels of those identified genes. A total of 151 genes were identified by Chip‐chip. The qPCR was performed on Daudi cells treated with IFN‐α or IFN‐β at 1, 3, 6, 12, 24, and 48 hours. Our results revealed that the STAT6 may be a positive or negative regulator on gene expression levels and the expression levels of those genes are time dependent. A more detail molecular studies will be performed to determine the biological functions of those genes.

The Importance of Stat6 Regulated Genes Activated by Type I Interferon